TrovaGene, Inc. (NASDAQ:TROV)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar NiksurfsInvestmt (40.93) Submitted: 12/20/2012 11:53:14 AM : Outperform Start Price: $6.18 TROV Score: -32.95

The applications for this technology now being adopted are enormous. Laboratory, in home testing .....

This company has an exciting future given it hits on all cylinders, lots of options going forward for licensing deals, co-branding, or just being taken out in a purchase. Any way you look at it this company is a real coiled spring, 2013 should be very interesting. Hold on the ride may get a bit bumpy but it will be worth it.

Featured Broker Partners


Advertisement